Cargando…

Biomarker Phenotypes in Heart Failure with Preserved Ejection Fraction Using Hierarchical Clustering: A Pilot Study

OBJECTIVES: We hypothesized the existence of distinct phenotype-based groups within the very heterogeneous population of patients of heart failure with preserved ejection fraction (HFpEF) and using an unsupervised hierarchical clustering applied to plasma concentration of various biomarkers. We soug...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mitic, Valentina, Stojanovic, Dijana, Deljanin Ilic, Marina, Petrovic, Dejan, Ignjatovic, Aleksandra, Milenkovic, Jelena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	S. Karger AG 2023
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10659697/ https://www.ncbi.nlm.nih.gov/pubmed/37734333 http://dx.doi.org/10.1159/000534155

Ejemplares similares

The Discriminatory Ability of Renalase and Biomarkers of Cardiac Remodeling for the Prediction of Ischemia in Chronic Heart Failure Patients With the Regard to the Ejection Fraction
por: Stojanovic, Dijana, et al.
Publicado: (2021)

Association of Plasma Renalase and Left Ventricle Mass Index in Heart Failure Patients Stratified to the Category of the Ejection Fraction: A Pilot Study
por: Stojanovic, Dijana, et al.
Publicado: (2019)

The Scientific Rationale for the Introduction of Renalase in the Concept of Cardiac Fibrosis
por: Stojanovic, Dijana, et al.
Publicado: (2022)

Exercise‐induced B‐lines in heart failure with preserved ejection fraction occur along with diastolic function worsening
por: Simonovic, Dejan, et al.
Publicado: (2021)

Renalase Challenges the Oxidative Stress and Fibroproliferative Response in COVID-19
por: Stojanovic, Dijana, et al.
Publicado: (2022)

The Multi-Faceted Nature of Renalase for Mitochondrial Dysfunction Improvement in Cardiac Disease
por: Stojanovic, Dijana, et al.
Publicado: (2023)

Microinflammation Factors in the Common Diseases of the Heart and Kidneys
por: Tasic, Danijela, et al.
Publicado: (2015)

Temporal Changes in Incidence Rates of the Most Common Gynecological Cancers in the Female Population in Central Serbia
por: Stojanovic, Miodrag M., et al.
Publicado: (2022)

Approaching Higher Dimension Imaging Data Using Cluster-Based Hierarchical Modeling in Patients with Heart Failure Preserved Ejection Fraction
por: Kobayashi, Yukari, et al.
Publicado: (2019)

Identification of distinct phenotypic clusters in heart failure with preserved ejection fraction
por: Uijl, Alicia, et al.
Publicado: (2021)

Plasma advanced oxidation products as an additional tool in assessment of post-infarction heart failure
por: Cvetkovic, Tatjana, et al.
Publicado: (2022)

Left atrial ejection fraction and outcomes in heart failure with preserved ejection fraction
por: Kanagala, Prathap, et al.
Publicado: (2019)

Platelet‐derived immuno‐inflammatory indices show best performance in early prediction of COVID‐19 progression
por: Milenkovic, Jelena, et al.
Publicado: (2022)

Heart failure with preserved ejection fraction
por: Rigolli, Marzia, et al.
Publicado: (2013)

Heart failure with preserved ejection fraction
por: ElGuindy, Ahmed, et al.
Publicado: (2012)

Importance of Demographic and Clinical Features in Evaluating the Severity of COVID-19 in Hospitalized Patients: A Serbian Retrospective Study in the First Pandemic Year
por: Aritonovic Pribakovic, Jelena, et al.
Publicado: (2023)

Heart Failure with Preserved Ejection Fraction—a Concise Review
por: Adamczak, Daria M., et al.
Publicado: (2020)

Biomarkers in heart failure with preserved ejection fraction
por: Meijers, W. C., et al.
Publicado: (2016)

Management of heart failure with preserved ejection fraction
por: Gard, Emma, et al.
Publicado: (2020)

Managing heart failure with preserved ejection fraction
por: Davidson, Alexander, et al.
Publicado: (2020)

Biomarkers in Heart Failure with Preserved Ejection Fraction
por: Bayes-Genis, Antoni, et al.
Publicado: (2022)

Comorbidities in heart failure with preserved ejection fraction
por: Deichl, Andrea, et al.
Publicado: (2022)

A pilot clinical trial of cell therapy in heart failure with preserved ejection fraction
por: Vrtovec, Bojan, et al.
Publicado: (2022)

Different Pathophysiology and Outcomes of Heart Failure With Preserved Ejection Fraction Stratified by K-Means Clustering
por: Harada, Daisuke, et al.
Publicado: (2020)

Circulating irisin levels in heart failure with preserved or reduced ejection fraction: A pilot study
por: Silvestrini, Andrea, et al.
Publicado: (2019)

Metabolomic Fingerprint of Heart Failure with Preserved Ejection Fraction
por: Zordoky, Beshay N., et al.
Publicado: (2015)

Clinical Phenotypes in Heart Failure With Preserved Ejection Fraction
por: Samson, Rohan, et al.
Publicado: (2016)

Animal models of heart failure with preserved ejection fraction
por: Conceição, G., et al.
Publicado: (2016)

Cell Therapy for Heart Failure With Preserved Ejection Fraction
por: Borlaug, Barry A., et al.
Publicado: (2016)

Hospitalisation in Patients With Heart Failure With Preserved Ejection Fraction
por: Nanayakkara, Shane, et al.
Publicado: (2018)

Modelling the complexity of heart failure with preserved ejection fraction
por: O’Gallagher, Kevin, et al.
Publicado: (2018)

Microvascular Rarefaction and Heart Failure With Preserved Ejection Fraction
por: Zeng, Heng, et al.
Publicado: (2019)

Heart Failure With Preserved Ejection Fraction: An Opportunity for Reflection
por: Gupta, Deepak K.
Publicado: (2017)

Strategies for management of heart failure with preserved ejection fraction
por: Winchester, David E.
Publicado: (2019)

Sarcopenic Obesity in Heart Failure With Preserved Ejection Fraction
por: Kirkman, Danielle L., et al.
Publicado: (2020)

Exercise echocardiography in aortic stenosis with preserved ejection fraction
por: Postolache, Adriana, et al.
Publicado: (2020)

Microvascular Dysfunction in Heart Failure With Preserved Ejection Fraction
por: D’Amario, Domenico, et al.
Publicado: (2019)

Therapeutic Stalemate in Heart Failure With Preserved Ejection Fraction
por: Samson, Rohan, et al.
Publicado: (2021)

The Gut Microbiome of Heart Failure With Preserved Ejection Fraction
por: Beale, Anna L., et al.
Publicado: (2021)

Cell Therapy in Heart Failure with Preserved Ejection Fraction
por: Frljak, Sabina, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ts2i8934vfpdaivhbqrebc6fmj